Helen Thackray

Helen Thackray

Chief Tech/Sci/R&D Officer bei BIOCRYST PHARMACEUTICALS, INC.

Vermögen: 1 Mio $ am 31.03.2024

55 Jahre
Health Technology
Consumer Services
Government

Profil

Helen M.
Thackray
is currently the Chief Research & Development Officer at BioCryst Pharmaceuticals, Inc. She is also a Member-Institutional Review Board at Holy Cross Hospital (Maryland).
In addition, she is an Assistant Clinical Professor at GW School of Medicine & Health Sciences.
Previously, Dr. Thackray served as an Independent Director at ImmunoGen, Inc. from 2021 to 2024.
She was also the Vice President-Clinical Product Development at Biosynexus, Inc. from 2001 to 2006.
From 2006 to 2021, she held the position of Chief Medical Officer & SVP-Clinical Development at GlycoMimetics, Inc. She was also a Member-Institutional Review Board at the National Center for Health Statistics.
Dr. Thackray obtained her undergraduate degree from Stanford University and her doctorate from GW School of Medicine & Health Sciences.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.03.2024 242 139 ( 0,12% ) 1 Mio $ 31.03.2024

Aktive Positionen von Helen Thackray

UnternehmenPositionBeginn
BIOCRYST PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 19.03.2021
Holy Cross Hospital (Maryland) Corporate Officer/Principal -
Gw School of Medicine & Health Sciences Corporate Officer/Principal 01.01.2000
Alle aktiven Positionen von Helen Thackray

Ehemalige bekannte Positionen von Helen Thackray

UnternehmenPositionEnde
IMMUNOGEN, INC. Director/Board Member 12.02.2024
GLYCOMIMETICS, INC. Chief Tech/Sci/R&D Officer 19.03.2021
Corporate Officer/Principal 01.01.2006
National Center for Health Statistics Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Helen Thackray im Detail an

Ausbildung von Helen Thackray

Stanford University Undergraduate Degree
Gw School of Medicine & Health Sciences Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Helen Thackray im Detail an

Beziehungen

68

Beziehungen ersten Grades

8

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
BIOCRYST PHARMACEUTICALS, INC.

Health Technology

IMMUNOGEN, INC.

Health Technology

GLYCOMIMETICS, INC.

Health Technology

Private Unternehmen3

Health Technology

Holy Cross Hospital (Maryland)

National Center for Health Statistics

Government

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Helen Thackray